Letter to the Editor: Effect of pre-transplant viral therapy on post-transplant hepatitis B virus reactivation in patients with hepatitis B-related hepatocellular carcinoma.
作者信息
Zhang Shengke, Huang Shangke, Yang Guanhu, Chi Hao
机构信息
Department of Clinical Medicine, Southwest Medical University.
Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
出版信息
Int J Surg. 2024 Aug 1;110(8):5270-5271. doi: 10.1097/JS9.0000000000001553.
Abstract
摘要
相似文献
1
Letter to the Editor: Effect of pre-transplant viral therapy on post-transplant hepatitis B virus reactivation in patients with hepatitis B-related hepatocellular carcinoma.致编辑的信：移植前病毒治疗对乙型肝炎相关肝细胞癌患者移植后乙型肝炎病毒再激活的影响
Int J Surg. 2024 Aug 1;110(8):5270-5271. doi: 10.1097/JS9.0000000000001553.
2
Post-transplant hepatitis B virus reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-centre retrospective cohort study in China.移植后乙型肝炎病毒再激活影响乙型肝炎相关肝细胞癌患者的预后：中国的一项双中心回顾性队列研究。
Int J Surg. 2024 Apr 1;110(4):2263-2274. doi: 10.1097/JS9.0000000000001141.
3
Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors.接受介入治疗联合酪氨酸激酶抑制剂及免疫检查点抑制剂的转化治疗的乙肝相关肝细胞癌患者术后乙肝病毒再激活及其对生存的影响
Front Cell Infect Microbiol. 2025 Jul 17;15:1598193. doi: 10.3389/fcimb.2025.1598193. eCollection 2025.
4
Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma.抗病毒治疗对 HBV 相关肝细胞癌且 HBV DNA 阴性患者肝切除术后 HBV 再激活及肝功能的影响
Oncotarget. 2017 Feb 28;8(9):15047-15056. doi: 10.18632/oncotarget.14789.
5
How does hepatitis B virus infection react to hepatocellular carcinoma treatment?乙型肝炎病毒感染对肝细胞癌治疗有何反应？
J Gastroenterol Hepatol. 2012 Jan;27(1):1-2. doi: 10.1111/j.1440-1746.2011.06950.x.
6
Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.乙型肝炎病毒相关性肝移植：适应证减少及趋势变化
World J Gastroenterol. 2015 Jul 14;21(26):8140-7. doi: 10.3748/wjg.v21.i26.8140.
7
Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.肝细胞癌部分肝切除术后患者围手术期乙型肝炎病毒复制再激活。
J Gastroenterol Hepatol. 2012 Jan;27(1):158-64. doi: 10.1111/j.1440-1746.2011.06888.x.
8
Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌治疗期间的乙型肝炎病毒感染管理
World J Gastroenterol. 2015 Jul 21;21(27):8249-55. doi: 10.3748/wjg.v21.i27.8249.
9
Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.活体肝移植后乙型肝炎病毒感染的结局：一项20年的单中心经验
Exp Clin Transplant. 2016 Apr;14(2):207-14. doi: 10.6002/ect.2015.0206. Epub 2016 Feb 11.
10
Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma.抗病毒治疗原发性无应答会影响乙型肝炎病毒相关肝细胞癌的预后。
BMC Cancer. 2023 Jun 20;23(1):564. doi: 10.1186/s12885-023-11059-y.
本文引用的文献
1
Post-transplant hepatitis B virus reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-centre retrospective cohort study in China.移植后乙型肝炎病毒再激活影响乙型肝炎相关肝细胞癌患者的预后：中国的一项双中心回顾性队列研究。
Int J Surg. 2024 Apr 1;110(4):2263-2274. doi: 10.1097/JS9.0000000000001141.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Hepatitis B and cancer: A practical guide for the oncologist.乙肝与癌症：肿瘤学家实用指南
Crit Rev Oncol Hematol. 2016 Feb;98:137-46. doi: 10.1016/j.critrevonc.2015.10.017. Epub 2015 Nov 6.
4
Management of chronic hepatitis B infection.慢性乙型肝炎感染的管理。
BMJ. 2015 Oct 21;351:h4263. doi: 10.1136/bmj.h4263.
Zotero 插件